Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL738611 | 1.00 | KDM4E (0.31) | KDM4EALDH1A1 | |
| SCHEMBL16259082 | 0.81 | CYP2D6 (0.38) | — | |
| SCHEMBL13887669 | 0.73 | — | — | |
| SCHEMBL14505652 | 0.68 | — | — | |
| SCHEMBL13488625 | 0.67 | GRIN2D (0.38) | — | |
| SCHEMBL16300038 | 0.67 | GRIN2D (0.38) | — | |
| SCHEMBL13488365 | 0.65 | SIGMAR1 (0.31) | — | |
| SCHEMBL12344049 | 0.65 | CASP2 (0.42) | ALDH1A1 | |
| SCHEMBL15384942 | 0.64 | — | — | |
| SCHEMBL1747674 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025083165-A1 | BRASSICA NAPUS PLANTS HAVING ENHANCED BLACKLEG RESISTANCE | BASF AGRICULTURAL SOLUTIONS US LLC (US) | 2025-04-24 | — | — | WO | disclosed |
| CN-109561676-B | Use of N-substituted pyrrolidones for promoting penetration of agrochemical active ingredients | 科莱恩国际有限公司 | 2022-04-29 | — | — | CN | disclosed |
| EP-2870248-A1 | BRASSICA ROD1 GENE SEQUENCES AND USES THEREOF | Bayer CropScience NV (BE) | 2015-05-13 | — | — | EP | disclosed |
| WO-2014006158-A1 | BRASSICA ROD1 GENE SEQUENCES AND USES THEREOF | BAYER CROPSCIENCE NV (BE) | 2014-01-09 | — | — | WO | disclosed |
| US-8138350-B2 | N′-cyano-N-halogenalkylimidamide derivatives | BAYER CROPSCIENCE AG (DE) | 2012-03-20 | — | — | US | disclosed |
| US-8138350-B2 | N′-cyano-N-halogenalkylimidamide derivatives | BAYER CROPSCIENCE AG (DE) | 2012-03-20 | — | — | US | disclosed |
| US-20100048646-A1 | N'-Cyano-N-Halogenalkylimidamide Derivatives | BAYER CROPSCIENCE AG (DE) | 2010-02-25 | — | — | US | disclosed |
| US-20100048646-A1 | N'-Cyano-N-Halogenalkylimidamide Derivatives | BAYER CROPSCIENCE AG (DE) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048646-A1 | N'-Cyano-N-Halogenalkylimidamide Derivatives | NCLN, NISCH, DDT | KDM4E 2289/4885ALDH1A1 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.